프로그램
Updated as of Nov-6, 2024
| 인사말 | 09:20-09:30 | |
| 1. Multi-omics design using paraffin-embedded tissue samples | 09:30-11:00 | |
| 1) Spatial transcriptome analysis for drug development | 박웅양 (삼성유전체연구소) | |
| 2) Spatial multi-omics research (using FFPE): A pathologist's perspective | 고재문 (서울의대) | |
| 3) Multi-omics cancer analysis : An analytical perspective | 구하림 (국립암센터) | |
| 패널토의 | ||
| Coffee Break | 11:00-11:20 | |
| 2. Next-generation T/NK-cell engaging therapeutics | 11:20-12:50 | |
| 1) IL-21 releasable armored CAR-T therapy for solid tumor | 서형석 (서울대) | |
| 2) NK cell biology and therapeutics | 김헌식 (울산의대) | |
| 3) T-cell engaging antibodies for hematologic and solid cancers | 김태민 (서울의대) | |
| 패널토의 | ||
| Lunch Break | 12:50-14:00 | |
| 3. Immuno-metabolisms in precision oncology | 14:00-15:30 | |
| 1) Key metabolic regulator of T cell in TME | 임선아 (이화여대) | |
| 2) Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in solid cancers | 박숙련 (울산의대) | |
| 3) Prediction of cancer-associated metabolites for drug targeting | 김현욱 (KAIST) | |
| 패널토의 | ||
| Coffee Break | 15:30-15:50 | |
| 4. Applications of genome editing technology in cancer therapy | 15:50-17:20 | |
| 1) Current status and challenges in genome editing | 배상수 (서울의대) | |
| 2) Cancer gene therapy using oncolytic adenovirus | 윤채옥 (한양대) | |
| 3) Exploring the status of AAV-based gene therapy and its applications in cancer treatment | 장재형 (연세대) | |
| 패널토의 | ||
